CTNNBIP1
Beta-catenin-interacting protein 1
Also known as: CNBP1_HUMAN, ICAT, MGC15093
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NSA3
- Gene
- CTNNBIP1
- Ensembl
- ENSG00000178585
- Chromosome
- 1
- Canonical length
- 81 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene binds CTNNB1 and prevents interaction between CTNNB1 and TCF family members. The encoded protein is a negative regulator of the Wnt signaling pathway. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
81 residues, UniProt reviewed canonical sequence.
>Q9NSA3|CTNNBIP1
1 MNREGAPGKS PEEMYIQQKV RVLLMLRKMG SNLTASEEEF LRTYAGVVNS QLSQLPPHSI
61 DQGAEDVVMA FSRSETEDRR QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTNNBIP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 410 nTPM
Expression across tissuesHPA
Tissue
- skin: 410 nTPM
- esophagus: 169 nTPM
- vagina: 80 nTPM
- epididymis: 73 nTPM
- cervix: 71 nTPM
- salivary gland: 49 nTPM
Single-cell type
- esophageal apical cells: 3,782 nCPM
- esophageal suprabasal cells: 1,437 nCPM
- suprabasal keratinocytes: 458 nCPM
- esophageal basal cells: 323 nCPM
- epididymal principal cells: 263 nCPM
- müller glia: 232 nCPM
Immune cell
- eosinophil: 14 nTPM
- NK-cell: 8.6 nTPM
- myeloid DC: 6.5 nTPM
- classical monocyte: 5.3 nTPM
- neutrophil: 3.7 nTPM
- basophil: 2.7 nTPM
Brain region
- thalamus: 67 nTPM
- cerebellum: 66 nTPM
- pons: 64 nTPM
- medulla oblongata: 53 nTPM
- cerebral cortex: 53 nTPM
- hypothalamus: 51 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTNNBIP1.
Disease | ImmuneIEDB
Conditions an epitope on CTNNBIP1 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior pattern specification
- branching involved in ureteric bud morphogenesis
- canonical Wnt signaling pathway
- negative regulation of canonical Wnt signaling pathway
- negative regulation of mesenchymal cell proliferation
- negative regulation of protein-containing complex assembly
- negative regulation of smooth muscle cell proliferation
- negative regulation of transcription by RNA polymerase II
- negative regulation of transcription initiation by RNA polymerase II
- negative regulation of Wnt signaling pathway
- positive regulation of monocyte differentiation
- positive regulation of osteoblast differentiation
- regulation of vascular permeability involved in acute inflammatory response
Molecular functions
- armadillo repeat domain binding
- beta-catenin binding
- transcription coactivator binding
- transcription regulator inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTNNBIP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTNNBIP1 as an antibody target. Whether an autoantibody or antibody against CTNNBIP1 could matter depends on whether native CTNNBIP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTNNBIP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTNNBIP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...